Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.7B | 7.9B | 7.6B | 7.6B |
Cost of revenue | 5.5B | 5.7B | 5.5B | 5.5B |
Gross profit | 2.1B | 2.3B | 2.1B | 2.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.3B | 1.3B | 1.2B | 1.3B |
Other operating expenses | 29M | 21M | 4M | 2M |
Operating income | 824M | 959M | 936M | 834M |
Non operating interest income | ||||
Income | 24M | 39M | 10M | 34M |
Expense | 197M | 202M | 216M | 213M |
Other income expense | — | — | — | — |
Pretax income | 531M | 555M | 659M | 550M |
Tax provision | 149M | 150M | 178M | 154M |
Net income | 382M | 405M | 481M | 396M |
Basic EPS | 5.6 | 5.9 | 6.9 | 5.7 |
Diluted EPS | 5.6 | 5.9 | 6.9 | 5.6 |
Basic average shares | 68.5M | 68.8M | 69.4M | 70.1M |
Diluted average shares | 68.6M | 69M | 69.6M | 70.2M |
EBITDA | 1.6B | 1.7B | 1.7B | 1.6B |
Net income from continuing op. | 531M | 555M | 659M | 550M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |